Are GLP-1s the First True Longevity Drug?
 | Newswise

Are GLP-1s the First True Longevity Drug? | Newswise

Newswise — With GLP-1 drugs dominating headlines for their impact on weight loss and metabolic health, new discussions around their potential role in extending healthy lifespan are emerging. Dr. Christoph Westphal, Co-founder and General Partner of Longwood Fund, and Dr. Jarod Rutledge, Biomarkers Lead at the Amaranth Foundation, highlight why GLP-1s could be the first…

Read More
Are GLP-1s the First True Longevity Drug?
 | Newswise

Aging in the 21st Century: The Urgent Need to Improve Healthspan | Newswise

With global aging trends accelerating, policymakers and researchers are increasingly focused on not just extending lifespan, but ensuring those extra years are lived in good health. Dr. Anshu Banerjee, Director for the Department of Maternal, Newborn, Child, and Adolescent Health and Ageing at the World Health Organization, emphasizes the widening gap between lifespan and healthspan…

Read More
Are GLP-1s the First True Longevity Drug?
 | Newswise

Hevolution Foundation Hosting Over 2,000 International Experts at the Second Global Healthspan Summit to Explore Ways to Extend Healthy Years of Life | Newswise

Taking place in Riyadh on February 4 and 5, 2025, the Global Healthspan Summit (GHS) will identify new pathways and frameworks to develop and create impact around extending healthy years of life, known as “healthspan.” Over 150 international speakers from the US, UK, Egypt, Germany, the Netherlands, Switzerland, Singapore, Spain, and Saudi Arabia will convene during more than 80 sessions and across six stages. With an annual…

Read More